Public Sector Pension Investment Board maintained its stake in Vitamin Shoppe Inc (NYSE:VSI) during the fourth quarter, Holdings Channel reports. The institutional investor owned 16,686 shares of the company’s stock at the end of the fourth quarter. Public Sector Pension Investment Board owned about 0.07% of Vitamin Shoppe worth $396,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Citadel Advisors LLC boosted its stake in Vitamin Shoppe by 20,677.9% in the third quarter. Citadel Advisors LLC now owns 228,557 shares of the company’s stock worth $6,137,000 after buying an additional 227,457 shares during the period. GMT Capital Corp bought a new stake in Vitamin Shoppe during the third quarter worth approximately $7,586,000. SG Americas Securities LLC bought a new stake in Vitamin Shoppe during the third quarter worth approximately $282,000. Stevens Capital Management LP boosted its stake in Vitamin Shoppe by 4.7% in the third quarter. Stevens Capital Management LP now owns 10,733 shares of the company’s stock worth $288,000 after buying an additional 479 shares during the period. Finally, Municipal Employees Retirement System of Michigan boosted its stake in Vitamin Shoppe by 1.5% in the third quarter. Municipal Employees Retirement System of Michigan now owns 5,380 shares of the company’s stock worth $144,000 after buying an additional 80 shares during the period.
Shares of Vitamin Shoppe Inc (NYSE:VSI) opened at 19.10 on Wednesday. Vitamin Shoppe Inc has a one year low of $18.25 and a one year high of $32.31. The company has a market cap of $440.27 million, a PE ratio of 18.37 and a beta of 0.59. The firm’s 50-day moving average is $21.04 and its 200-day moving average is $24.20.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, March 1st. The company reported $0.36 EPS for the quarter, missing the Zacks’ consensus estimate of $0.40 by $0.04. Vitamin Shoppe had a net margin of 3.34% and a return on equity of 11.52%. The firm had revenue of $304.87 million for the quarter, compared to analysts’ expectations of $311.79 million. During the same quarter in the previous year, the company earned $0.39 EPS. The company’s quarterly revenue was up 3.9% compared to the same quarter last year. On average, equities analysts anticipate that Vitamin Shoppe Inc will post $2.04 EPS for the current year.
A number of equities research analysts recently commented on the stock. Zacks Investment Research raised shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Tuesday, December 27th. Morgan Stanley cut shares of Vitamin Shoppe from an “equal weight” rating to an “underweight” rating and set a $22.00 price target on the stock. in a report on Tuesday, January 17th. Finally, Goldman Sachs Group Inc cut shares of Vitamin Shoppe from a “neutral” rating to a “sell” rating and set a $21.00 price target on the stock. in a report on Thursday, January 19th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $29.33.
In other news, Director B. Michael Becker sold 2,729 shares of the stock in a transaction that occurred on Wednesday, March 8th. The shares were sold at an average price of $19.41, for a total transaction of $52,969.89. Following the sale, the director now owns 2,279 shares in the company, valued at $44,235.39. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Richard L. Markee sold 100,000 shares of the stock in a transaction that occurred on Friday, March 3rd. The shares were sold at an average price of $22.24, for a total transaction of $2,224,000.00. Following the sale, the director now owns 160,990 shares in the company, valued at approximately $3,580,417.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 108,161 shares of company stock worth $2,398,429. Corporate insiders own 1.29% of the company’s stock.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc (NYSE:VSI).